Anesthesiology, Pain Medicine · Houston, TX
NPI
1790946051
Since 2008
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
8,214 services
Medicare patients, 2024
652
Average age 73
Drug cost, 2024
$318K
9,031 prescriptions
Company payments, 2025
$37K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell P Engle was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 2,270 times for 161 patients. In total Mitchell P Engle billed 8,214 services in 76 codes, and Medicare paid $324K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-30.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,270 | 161 | $0.71 | $1,612 |
| 99214 Office E&M - Established | Office | 862 | 400 | $86.81 | $75K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 610 | 48 | $0.08 | $50 |
| 99213 Office E&M - Established | Office | 336 | 198 | $61.34 | $21K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 175 | 60 | $45.74 | $8,004 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 149 | 44 | $54.91 | $8,181 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 142 | 58 | $100.52 | $14K |
| 99442 Telephone Services | Office | 139 | 106 | $61.73 | $8,580 |
| 64483 Nerve Block Injection - Back | Office | 116 | 93 | $219.06 | $25K |
| 99204 Office E&M - New | Office | 113 | 113 | $114.28 | $13K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 98 | 52 | $35.29 | $3,459 |
| 96372 Injection Administration | Office | 84 | 48 | $9.69 | $814 |
| 62370 Musculoskeletal | Office | 83 | 24 | $54.07 | $4,488 |
| 27096 Joint Injection | Office | 80 | 60 | $159.76 | $13K |
| 76942 Ultrasound - Nonspecific | Office | 79 | 25 | $34.56 | $2,730 |
By year: 2022 $205K for 4,203 services; 2023 $274K for 6,298 services; 2024 $324K for 8,214 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell P Engle prescribed most often to Medicare patients was Tramadol Hcl, with 1,201 prescriptions and refills. In total Mitchell P Engle wrote 9,031 Medicare prescriptions that cost $318K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tramadol Hcl Generic | 1,201 | 1,204 | 258 | $17K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 1,048 | 1,048 | 251 | $21K |
| Gabapentin Generic | 996 | 1,394 | 274 | $18K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 879 | 879 | 164 | $27K |
| Tizanidine Hcl Generic | 688 | 874 | 208 | $9,266 |
| Pregabalin Generic | 683 | 875 | 171 | $14K |
| Oxycodone Hcl Generic | 360 | 360 | 72 | $5,364 |
| Duloxetine Hcl Generic | 306 | 380 | 121 | $4,981 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 275 | 275 | 57 | $8,085 |
| Morphine Sulfate Generic | 264 | 270 | 48 | $7,637 |
| Cyclobenzaprine Hcl Generic | 239 | 298 | 77 | $3,778 |
| Methocarbamol Generic | 158 | 164 | 48 | $2,923 |
| Celecoxib Generic | 148 | 167 | 38 | $1,817 |
| Buprenorphine Hcl Generic | 145 | 145 | 45 | $4,369 |
| Morphine Sulfate Er Morphine Sulfate | 133 | 133 | 17 | $4,960 |
Brand drugs: 354 claims; generic drugs: 8,677 claims; opioid claims: 4,549.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitchell P Engle $37K ($37K in general payments such as food, travel and fees) from 13 companies. The largest payer was Boston Scientific Corporation with $31K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.